Keisuke Yusa

869 total citations
42 papers, 719 citations indexed

About

Keisuke Yusa is a scholar working on Virology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Keisuke Yusa has authored 42 papers receiving a total of 719 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Virology, 21 papers in Infectious Diseases and 11 papers in Molecular Biology. Recurrent topics in Keisuke Yusa's work include HIV Research and Treatment (24 papers), HIV/AIDS drug development and treatment (19 papers) and Immune Cell Function and Interaction (10 papers). Keisuke Yusa is often cited by papers focused on HIV Research and Treatment (24 papers), HIV/AIDS drug development and treatment (19 papers) and Immune Cell Function and Interaction (10 papers). Keisuke Yusa collaborates with scholars based in Japan, United States and China. Keisuke Yusa's co-authors include Shinji Harada, Hiroaki Mitsuya, Yosuke Maeda, Eiichi Kodama, Ronald P. McCaffrey, Takashi Tsuruo, Kazuaki Monde, Mark F. Kavlick, T Tsuruo and N. KATAGIRI and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Keisuke Yusa

39 papers receiving 690 citations

Peers

Countries citing papers authored by Keisuke Yusa

Since Specialization

Citations

This map shows the geographic impact of Keisuke Yusa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keisuke Yusa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keisuke Yusa more than expected).

Fields of papers citing papers by Keisuke Yusa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keisuke Yusa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keisuke Yusa. The network helps show where Keisuke Yusa may publish in the future.

Co-authorship network of co-authors of Keisuke Yusa

This figure shows the co-authorship network connecting the top 25 collaborators of Keisuke Yusa. A scholar is included among the top collaborators of Keisuke Yusa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keisuke Yusa. Keisuke Yusa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Encapsulation of a Single-Stranded Form of DNA Impurities into the Capsid of a Recombinant Adeno-Associated Virus 2025 ·Human Gene Therapy ·Kazuhisa Uchida, (unknown), (unknown), (unknown), Keisuke Yusa, (unknown)	0
2	Stabilization of a single-stranded DNA of adeno-associated virus by inverted terminal repeats 2024 ·Scientific Reports ·(unknown), (unknown), (unknown), (unknown), Keisuke Yusa, Kazuhisa Uchida	1
3	Association between adeno‐associated virus genomic titers and intracellular plasmid levels 2023 ·Engineering Reports ·(unknown), (unknown), (unknown), Keisuke Yusa, Kazuhisa Uchida	0
4	Quantitation of Residual Host Cell DNA in Recombinant Adeno-Associated Virus Using Droplet Digital Polymerase Chain Reaction 2023 ·Human Gene Therapy ·(unknown), (unknown), (unknown), (unknown), Keisuke Yusa, Kazuhisa Uchida	7
5	Concise Analysis of Single-Stranded DNA of Recombinant Adeno-Associated Virus By Automated Electrophoresis System 2023 ·Human Gene Therapy ·(unknown), (unknown), (unknown), (unknown), Keisuke Yusa, Kazuhisa Uchida	2
6	A highly sensitive method for the detection of recombinant PERV-A/C env RNA using next generation sequencing technologies 2020 ·Scientific Reports ·Ken Kono, Kiyoko Kataoka, (unknown), Keisuke Yusa, Kazuhisa Uchida, Yoji Sato	7
7	Preferential recognition of monomeric CCR5 expressed in cultured cells by the HIV-1 envelope glycoprotein gp120 for the entry of R5 HIV-1 2014 ·Virology ·Yusuke Nakano, Kazuaki Monde, (unknown), (unknown), Keisuke Yusa, Shinji Harada, Yosuke Maeda	12
8	Structure and Dynamics of the gp120 V3 Loop That Confers Noncompetitive Resistance in R5 HIV-1JR-FL to Maraviroc 2013 ·PLoS ONE ·(unknown), Masaru Yokoyama, Yosuke Maeda, (unknown), Shinji Harada, Hironori Sato, Keisuke Yusa	16
9	Altered sensitivity of an R5X4 HIV-1 strain 89.6 to coreceptor inhibitors by a single amino acid substitution in the V3 region of gp120 2007 ·Antiviral Research ·Yosuke Maeda, Keisuke Yusa, Shinji Harada	14
10	A broad antiviral neutral glycolipid, fattiviracin FV-8, is a membrane fluidity modulator 2006 ·Cellular Microbiology ·Shinji Harada, Kazumi Yokomizo, Kazuaki Monde, Yosuke Maeda, Keisuke Yusa	17
11	Influence of membrane fluidity on human immunodeficiency virus type 1 entry 2005 ·Biochemical and Biophysical Research Communications ·Shinji Harada, Keisuke Yusa, Kazuaki Monde, Takaaki Akaike, Yosuke Maeda	22
12	Enhanced infectivity of HIV-1 by X4 HIV-1 coinfection 2003 ·Biochemical and Biophysical Research Communications ·Yosuke Maeda, Keisuke Yusa, Shinji Harada	1
13	Enhanced Infection of an X4 Strain of HIV-1 Due to Capping and Colocalization of CD4 and CXCR4 Induced by Capsianoside G, a Diterpene Glycoside 2001 ·Biochemical and Biophysical Research Communications ·Wei Song, Shoji Yahara, (unknown), Keisuke Yusa, Yuetsu Tanaka, Shinji Harada	9
14	HIV-1 acquires resistance to two classes of antiviral drugs through homologous recombination 1997 ·Antiviral Research ·Keisuke Yusa, Mark F. Kavlick, Pope Kosalaraksa, Hiroaki Mitsuya	32
15	Resolution of 9-(c-4,t-5-bishydroxymethylcyclopent-2-en-r-1-yl)-9H-adenine and selective inhibition of human immunodeficiency virus by the (−) enantiomer 1992 ·Biochemical and Biophysical Research Communications ·Nobuya Katagiri, Takuya Shiraishi, Hiroshi Satō, (unknown), Chikara Kaneko, Keisuke Yusa, Tomoko Oh‐hara, Takashi Tsuruo	10
16	Synthesis and anti-HIV activity of 9-[c-4,t-5-bis(hydroxymethyl)cyclopent-2-en-r-1-yl]-9H-adenine 1992 ·Journal of Medicinal Chemistry ·N. KATAGIRI, Masahiro Nomura, Hirotoshi Sato, (unknown), Keisuke Yusa, T Tsuruo	52
17	Cross-resistance to anti-HIV nucleoside analogs in multidrug-resistant human cells 1990 ·Biochemical and Biophysical Research Communications ·Keisuke Yusa, Tomoko Oh‐hara, Akiko Yamazaki, Satomi Tsukahara, (unknown), Takashi Tsuruo	26
18	Low Metastatic Potential of Clone From Murine Colon Adenocarcinoma 26 Increased by Transfection of Activated c-erbB-2 Gene 1990 ·JNCI Journal of the National Cancer Institute ·Keisuke Yusa, Yoshikazu Sugimoto, Takao Yamori, Tadashi Yamamoto, Kumao Toyoshima, Takashi Tsuruo	29
19	Antitumor Activity of ME2303, a Fluorine‐containing Anthracycline, against Human Tumors Implanted in Nude Mice 1989 ·Japanese Journal of Cancer Research ·Takashi Tsuruo, Shigeo Sato, Keisuke Yusa	4
20	Comparison of glutathione S-transferase activity between drug-resistant and-sensitive human tumor cells: Is glutathione S-transferase associated with multidrug resistance? 1988 ·Cancer Chemotherapy and Pharmacology ·Keisuke Yusa, Hirofumi Hamada, Takashi Tsuruo	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact